Dynorphin A Boosts Immune Cell Engulfing Ability Through a Non-Opioid Mechanism | Research

The takeaway

Dynorphin A dose-dependently enhanced macrophage phagocytosis through a naloxone-insensitive mechanism, while enkephalins and other peptides had no effect.

Non-opioid immune boost
Dynorphin A enhanced phagocytosis through a naloxone-insensitive mechanism — immune benefits without opioid receptor activation

What the researchers found

Dynorphin A dose-dependently enhanced macrophage phagocytosis through a naloxone-insensitive (non-opioid receptor) mechanism.

Why it matters

Dynorphin A has immune-boosting effects beyond its known role in pain. The non-opioid mechanism means these immune effects could potentially be harnessed without triggering opioid side effects.

How the study worked

Mouse peritoneal macrophage phagocytosis was measured by flow cytometry after treatment with dynorphin A and related peptides. Naloxone was used to test opioid receptor involvement.

What this study cannot tell us

In vitro study using mouse macrophages. The non-opioid mechanism is not identified. Whether this effect occurs in living animals is unknown.

How to read the evidence

Preliminary — in vitro study with flow cytometry. Non-opioid mechanism not identified.

When this study was published

Published in 1995 (31 years ago). Non-opioid actions of dynorphin continue to be studied.

The bigger picture

Dynorphin A has immune-boosting effects through a non-opioid mechanism. This means it could potentially be developed as an immune enhancer without causing the pain, mood, or addiction effects associated with opioid receptor activation.

Questions still open

What non-opioid receptor mediates dynorphin's phagocytosis enhancement?
Could dynorphin-based drugs boost immunity in immunocompromised patients?

Common questions

How does dynorphin boost immunity?

Dynorphin A enhances macrophages' ability to engulf and destroy pathogens through a mechanism that doesn't involve opioid receptors. The specific receptor or signaling pathway is not yet identified.

Could this be developed into a drug?

Potentially. Since the immune-boosting effect doesn't require opioid receptor activation, a dynorphin-based drug could enhance immunity without causing pain, mood, or addiction-related side effects.

Read the original research

Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages.

Journal of neuroimmunology, 60(1-2), 37-43

View on PubMed ↗

Citation

Ichinose, M; Asai, M; Sawada, M. (1995). Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages.. Journal of neuroimmunology, 60(1-2), 37-43.